Who owns BRIGHT MINDS BIOSCIENCES INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of DRUG from SEC Form 13F filings across 99 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 99 institutions disclosed 9.3M shares of BRIGHT MINDS BIOSCIENCES INC. worth $653.8M — about 94.7% of shares outstanding; the largest disclosed holder is Jupiter Topco LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
99
13F holders
$653.8M
value, 2026 filers
94.7%
of shares outstanding (9.3M sh)
19
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of DRUG's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Jupiter Topco LLCNEW | 1.3M | $94.8M | 0.0% | 13.7% | new |
| 2 | Cormorant Asset Management, LP | 900,000 | $63.2M | 3.2% | 9.2% | -15.0% |
| 3 | BlackRock, Inc. | 686,184 | $48.2M | 0.0% | 7% | +10.3% |
| 4 | Vivo Capital, LLC | 557,172 | $39.1M | 3.6% | 5.7% | 0.0% |
| 5 | Vestal Point Capital, LP | 545,000 | $38.3M | 0.9% | 5.5% | +10.7% |
| 6 | BRAIDWELL LP | 483,822 | $34.0M | 1.3% | 4.9% | -10.4% |
| 7 | Driehaus Capital Management LLC | 433,377 | $30.4M | 0.2% | 4.4% | +0.2% |
| 8 | Balyasny Asset Management L.P. | 345,053 | $24.2M | 0.0% | 3.5% | +16.1% |
| 9 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 335,000 | $23.5M | 0.0% | 3.4% | -32.4% |
| 10 | Point72 Asset Management, L.P.NEW | 327,416 | $23.0M | 0.0% | 3.3% | new |
| 11 | DEERFIELD MANAGEMENT COMPANY, L.P. | 283,000 | $19.9M | 0.2% | 2.9% | 0.0% |
| 12 | RA CAPITAL MANAGEMENT, L.P. | 265,000 | $18.6M | 0.2% | 2.7% | 0.0% |
| 13 | Parkman Healthcare Partners LLC | 205,053 | $14.4M | 1.5% | 2.1% | +411.4% |
| 14 | MPM BIOIMPACT LLC | 202,114 | $14.2M | 0.9% | 2.1% | -4.7% |
| 15 | WELLINGTON MANAGEMENT GROUP LLP | 171,315 | $12.0M | 0.0% | 1.7% | +25.3% |
| 16 | GOLDMAN SACHS GROUP INC | 133,689 | $9.4M | 0.0% | 1.4% | +79.8% |
| 17 | EVENTIDE ASSET MANAGEMENT, LLC | 130,013 | $9.1M | 0.1% | 1.3% | 0.0% |
| 18 | STATE STREET CORP | 122,178 | $8.6M | 0.0% | 1.2% | +12.9% |
| 19 | SEVEN GRAND MANAGERS, LLC | 120,000 | $8.4M | 0.3% | 1.2% | 0.0% |
| 20 | GREAT POINT PARTNERS LLC | 109,603 | $7.7M | 1.5% | 1.1% | -50.2% |
| 21 | GEODE CAPITAL MANAGEMENT, LLC | 104,146 | $7.3M | 0.0% | 1.1% | +17.4% |
| 22 | ORBIMED ADVISORS LLC | 93,000 | $6.5M | 0.1% | 0.9% | +132.5% |
| 23 | ACUTA CAPITAL PARTNERS, LLC | 92,745 | $6.5M | 4.5% | 0.9% | -17.2% |
| 24 | Ikarian Capital, LLC | 88,951 | $6.2M | 0.7% | 0.9% | -46.6% |
| 25 | VANGUARD PORTFOLIO MANAGEMENT LLC | 80,060 | $5.6M | 0.0% | 0.8% | +32.4% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.